A pattern is emerging across sectors that needs more direct attention from executive boards. As regulatory fragmentation accelerates across geographies, the companies most at risk are not those struggling to comply with individual policy and regulatory regimes. The ones really at risk are those that are responding to fragmentation with fragmented narratives, and the consequences are beginning to show up where it matters most: in investor trust, analyst confidence, and ultimately, brand and enterprise value.

Avoid contradictions that erode trust

In pharmaceutical M&A, dealmakers are simultaneously managing US FTC scrutiny, EU merger control regimes, and a UK CMA that has demonstrated increasing independence since Brexit. Each jurisdiction demands a distinct compliance posture, and companies must tread carefully to avoid presenting not just distinct postures, but contradictory stories about the strategic rationale behind the same transaction. What is framed as a pro-innovation consolidation in Washington can become a market concentration risk in Brussels. The buy-side analysts watching both conversations are not blind to the inconsistency.

“The temptation to present tailored stories to different regulators is understandable, especially from a compliance perspective.”

The EU AI Act is creating a parallel stress fracture in life sciences and technology. Companies embedding AI into drug discovery, diagnostics, and clinical trial design face overlapping obligations such as high-risk classification thresholds in Europe, sector-specific FDA guidance in the US, and an evolving UK framework still finding its post-GDPR footing. The temptation to present tailored stories to different regulators is understandable, especially from a compliance perspective.

Aerospace is another case in point. Supply chain safety scrutiny has forced manufacturers and tier-one suppliers into a communications environment where every statement made to a congressional committee, to the UK CAA, or to EASA, is cross-referenced by journalists, short-sellers, and institutional investors in real time. Increasingly, that cross-referencing is done by AI-powered investor-intelligence and regulatory-tracking platforms, which ingest regulatory narratives, media coverage, and ESG filings, then surface perceived inconsistencies in real-time dashboards and summaries. Such platforms do not simply reveal contradictions, they can reproduce and amplify them, turning subtle narrative misalignments into visible governance red flags before executives are aware anything has shifted.

And then there is CSRD. The EU’s Corporate Sustainability Reporting Directive is compelling companies to articulate their ESG commitments with a level of accountability that most corporate sustainability narratives were never designed to survive. Investor skepticism is already running high: 94% of investors believe corporate sustainability reports contain unsupported claims, and 85% say greenwashing concerns have grown more acute over the past five years.² Research from MIT and Harvard has found that ESG rating agencies can diverge by as much as 60% in their assessments of the same company.³ Companies operating across the EU, US, and UK are sometimes producing reports that, read side by side, describe entirely different organisations.

Why fragmented narratives erode value

The financial markets have noticed. Brunswick Group’s 2026 US Investor Survey, drawing on 100 institutional active-equity investors, found that 93% would not invest in a company without trust in management, even with strong financials and an attractive market opportunity.⁴ More pointedly, 85% had sold a position due to a loss of trust in management, with changing the narrative or strategy without clear explanation ranked among the most damaging trust-destroying behaviours.⁴ In a world where a company’s position papers in Brussels, regulatory submissions in Washington, and shareholder communications in London can be cross-referenced within minutes, narrative inconsistency is no longer an abstract risk. It is a sell signal.

“Once trust erodes with a sophisticated investor audience, it rarely recovers on the back of a press release.”

This is the underappreciated dimension of regulatory fragmentation: it is not just a compliance cost. It is a brand stress test. The 2026 Edelman Trust Barometer found that trust is in a state of acute fragility across developed markets including the UK, Germany, and the US, with institutional insularity at record highs.⁵ Companies appearing to say different things to different audiences do not merely confuse. They confirm suspicions. And once trust erodes with a sophisticated investor audience, it rarely recovers on the back of a press release.

The accountability gap

In most organisations, brand coherence is still treated as a downstream communications issue managed after strategic decisions are made, not integrated into how those decisions are framed from the outset. Public affairs teams brief Brussels. IR teams brief the City. Sustainability functions manage CSRD. Legal manages regulatory submissions. Almost no one is accountable for the coherence of the whole. The Harvard Law School Forum on Corporate Governance has called this the invisible governance risk, the fracture that occurs not inside the company, but the moment its story reaches external stakeholders simultaneously holding conflicting versions of it.⁶

This cannot remain a communications problem. It needs to become a governance priority.

What executive leadership boards should do now

The path forward is neither simple nor purely structural, but it is clear. Four things stand out.

First, appoint a cross-functional narrative owner. Whether that sits with the Chief Public Affairs Officer, a Chief Strategy Officer, or the General Counsel, someone must be accountable for the coherence of the company’s story across jurisdictions, not just its accuracy within each one.

Second, build regulatory narrative alignment into deal and policy processes. Before a transaction closes, before a regulatory position is filed, before a sustainability report is published, the cross-jurisdictional story should be stress-tested. Not for legal consistency alone, but for reputational coherence. Executive boards should be asking: would a sophisticated investor reading our Brussels filing alongside our 10-K recognise the same company?

Third, treat brand coherence as a capital markets input, not a communications output. Chief Communications Officers and Public Affairs leaders need genuine seats at the strategic table, present when positions are formed, not summoned when they need to be packaged. The Brunswick data is unambiguous: investor trust is built through consistency over time, not recovered through reactive messaging.⁴

“The stress test is already running. The question is whether your company is equipped to pass it.”

Fourth, audit your fragmentation exposure. Most large organisations do not have a clear picture of how their regulatory narratives map against each other across jurisdictions. Commissioning that audit through a cross-functional working group or an external adviser is a modest investment against the cost of a valuation discount or a reputational issue that could have been avoided.

Regulatory complexity is not going away. The EU will continue to legislate ahead of the curve. The US will continue to diverge. The UK will continue to define its own post-Brexit path, beyond the current Labour government’s rapprochement efforts. The companies that emerge from this period with reputations and valuations intact will be those that treat brand coherence not as a messaging discipline, but as a governance discipline.

Markus Leutert, Corporate Affairs Expert